Different roles for K+ channels in cisplatin-resistant cell lines argue against a critical role for these channels in cisplatin resistance.
暂无分享,去创建一个
M. Gottesman | G. Szakács | J. Annereau | Xing-jie Liang | S. Wincovitch | S. Garfield | Jun-Jie Yin | C. Cardarelli | A. Aszalos | B. Taylor | A. Aszalós
[1] H. Hansen,et al. Magnesium and potassium homeostasis during cisplatin treatment , 2005, Cancer Chemotherapy and Pharmacology.
[2] John N Weinstein,et al. Analysis of ATP-Binding Cassette Transporter Expression in Drug-Selected Cell Lines by a Microarray Dedicated to Multidrug Resistances⃞ , 2004, Molecular Pharmacology.
[3] Jie Huang,et al. Down-regulation of Bcl-2 is associated with cisplatin resistance in human small cell lung cancer H69 cells. , 2004, Molecular cancer therapeutics.
[4] L. Kèlland,et al. Selective potentiation of platinum drug cytotoxicity in cisplatin-sensitive and-resistant human ovarian carcinoma cell lines by amphotericin B , 2004, Cancer Chemotherapy and Pharmacology.
[5] Z. Siddik,et al. Cisplatin: mode of cytotoxic action and molecular basis of resistance , 2003, Oncogene.
[6] M. Gottesman,et al. Mislocalization of membrane proteins associated with multidrug resistance in cisplatin-resistant cancer cell lines. , 2003, Cancer research.
[7] C. Cullinane,et al. Gemcitabine potentiates cisplatin cytotoxicity and inhibits repair of cisplatin-DNA damage in ovarian cancer cell lines. , 2003, Molecular pharmacology.
[8] D. A. Brown,et al. Dominant-Negative Subunits Reveal Potassium Channel Families That Contribute to M-Like Potassium Currents , 2002, The Journal of Neuroscience.
[9] Toshitaka Nakamura,et al. Elevated expression of vacuolar proton pump genes and cellular ph in cisplatin resistance , 2001, International journal of cancer.
[10] K. Maheswari,et al. Interaction of cisplatin with planar model membranes - dose dependent change in electrical characteristics. , 2000, Biochimica et biophysica acta.
[11] K. Paull,et al. Oxaliplatin, tetraplatin, cisplatin, and carboplatin: spectrum of activity in drug-resistant cell lines and in the cell lines of the National Cancer Institute's Anticancer Drug Screen panel. , 1996, Biochemical pharmacology.
[12] J. Glockner,et al. CHAPTER 21 – MEASUREMENTS OF THE CONCENTRATION OF OXYGEN IN BIOLOGICAL SYSTEMS USING EPR TECHNIQUES , 1989 .
[13] J. Bolard,et al. Recovery of hepatocytes from attack by the pore former amphotericin B. , 1988, The Biochemical journal.
[14] D. Schlessinger,et al. Stimulatory, permeabilizing, and toxic effects of amphotericin B on L cells , 1984, Antimicrobial Agents and Chemotherapy.